Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

INTRODUCTION: Diffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuohy, Kyle, Ba, Djibril M., Bhanja, Debarati, Leslie, Douglas, Liu, Guodong, Mansouri, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935584/
https://www.ncbi.nlm.nih.gov/pubmed/36816005
http://dx.doi.org/10.3389/fsurg.2023.1001741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935584/
https://www.ncbi.nlm.nih.gov/pubmed/36816005
http://dx.doi.org/10.3389/fsurg.2023.1001741

Ejemplares similares